The S&P 500 has now lost ground four sessions in a row, the Nasdaq has slipped into correction territory, and the selling keeps coming back to the same theme: AI worries. Salesforce dropped more than 9% on fears that AI will replace software, and a string of technology outages only added to the anxiety. Nvidia’s report is finally out, and it was a good one, with results that beat expectations and gave AI peers a lift after hours. But one strong report doesn’t erase the broader unwind in AI investment that has been dragging on the market.
That’s why I’m staying away from headline-driven sectors right now. Tech is whipsawing on every AI headline, and energy has been swinging with the Iran and oil news. Neither is giving me the clean, predictable behavior I want in a trade. Instead, I want to find areas that are insulated from the AI story, and that’s exactly where the Stock Forecast Toolbox helps me. Try it out for free!

Did you miss Keith’s reveal in his Market Flash Briefing? He is harnessing this volatility in a way no one would expect and he just put it all on the table. Catch the replay here.
CVS isn’t an AI trade and doesn’t behave like one. It combines retail pharmacies, pharmacy benefit management and the Aetna insurance business, so it isn’t as dependent on any single policy decision as a pure insurer. To be fair, healthcare wasn’t immune today, with insurers like UnitedHealth pressured by new Medicare and Medicaid anti-fraud proposals. But that’s a policy headline with nothing to do with AI, and it’s one more reason to keep the position size reasonable. Here’s what the Toolbox projects:

The model is pointing to a target of just over $94 over the next two weeks. To play it, I’m looking at the December 18th $87.50 call, currently trading for $2.45. If CVS gets to $94, that call would be worth at least $6.50, a gain of roughly 165%. I’m not counting on hitting the full target, and a double on this trade would be a great result. The December expiration gives the stock some breathing room beyond that two-week window, but I plan to take profits as the stock approaches the target rather than waiting around for expiration.
In a market where so much of the action is being driven by AI headlines, finding something that marches to its own beat is worth a lot. That’s the kind of setup the Toolbox is built to uncover.
As a reminder, the Forecast Toolbox doesn’t just give me one prediction every week or every day. It models out high probability moves for most listed stocks in the market. I can check every stock in my portfolio to make sure I’m positioned right when I’m holding my investments, and when I’m looking for a new trade, it provides a filtered list of some of the most explosive setups so I can find the next great idea for my trading portfolio.
Make sure to take advantage of the free 7-Day Trial of the Stock Forecast Toolbox so you can see what it can do for you!
If you have any questions, never hesitate to reach out.
Keith Harwood
Keith@OptionHotline.com
Recent Comments